AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2009
Mar 30, 2009
35119_dirs_2009-03-30_ebe067e8-e3ed-4e64-9dd1-1a6d44cf56b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-03-27
Reporting Person: Brey Robert N (Chief Scientific Officer/SrVP)
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3